Parexel Announces Strategic Collaboration with Synexa Life Sciences and Drawbridge Health for COVID-19 Clinical Serology Testing Solution
November 02, 2020 09:30 ET
|
Parexel International LLC
BOSTON and DURHAM, N.C., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative therapies to improve world health, from...
Parexel Biotech Collaborates with Synairgen on Pivotal Phase III Trial for Study of Inhaled COVID-19 Treatment
October 20, 2020 07:00 ET
|
Parexel International LLC
BOSTON and DURHAM, N.C., Oct. 20, 2020 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative therapies to improve world health, from...
Parexel and Innoplexus Unveil Single Source of COVID-19 Information for Researchers, Sponsors and Patients During the Pandemic
September 24, 2020 09:00 ET
|
Parexel International LLC
BOSTON and DURHAM, N.C. and ESCHBORN, Germany , Sept. 24, 2020 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to...
Parexel Completes Purchase of Roam Analytics’ Natural Language Processing Capability
September 22, 2020 11:35 ET
|
Parexel International LLC
BOSTON and DURHAM, N.C., Sept. 22, 2020 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative therapies to improve world health, from...
Parexel Announces Solution for EU Clinical Trials Information System Regulation
September 21, 2020 09:00 ET
|
Parexel International LLC
BOSTON and DURHAM, N.C., Sept. 21, 2020 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative therapies to improve world health, from...
Parexel and Pfizer Enter Next Phase of Decade-Long Partnership
August 27, 2020 09:00 ET
|
Parexel International LLC
BOSTON and DURHAM, N.C., Aug. 27, 2020 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to improve world health,...
Parexel’s Deb Tatton Named to 2020 PharmaVOICE 100
August 03, 2020 09:00 ET
|
Parexel International LLC
BOSTON and DURHAM, N.C., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to market to improve world...
Parexel Expands Global Regulatory Capabilities with Experts from FDA, EMA, NMPA and Spanish AEMPS
July 23, 2020 09:00 ET
|
Parexel International LLC
BOSTON and DURHAM, N.C., July 23, 2020 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to improve world health,...
Parexel and TriNetX Partner to Advance Real-world Data Use in Clinical Development
June 18, 2020 08:00 ET
|
Parexel International LLC
BOSTON and DURHAM, N.C., and CAMBRIDGE, Mass., June 18, 2020 (GLOBE NEWSWIRE) -- Parexel and TriNetX today announced a strategic effort through which they will securely connect healthcare data to...
Parexel Adds APANDEMIC and Datavant to Lead Ongoing Advancement of #KeepingPatientsFirst Platform
June 16, 2020 09:00 ET
|
Parexel International LLC
BOSTON and DURHAM, N.C., June 16, 2020 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to improve world health,...